NetworkNewsBreaks – Lexaria Bioscience Corp. (CS
Post# of 721
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) on Friday announced that it is expanding to hire new personnel and will be issuing stock options. Per the update, Lexaria is in the process of appointing a new corporate controller, head of its legal division and other office staff, and, in 2019, it expects to hire additional laboratory personnel with expansion of its research and development operations. As a result of the newly-created positions, Lexaria is issuing stock options totaling 240,000 with an exercise price of $1.06. In addition, the company has received $110,000 from the exercise of 250,000 previously-granted warrants with an exercise price of $0.44.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer